Prognosis of histological cirrhosis in type 1 autoimmune hepatitis

Gastroenterology
S K RobertsA J Czaja

Abstract

Cirrhosis connotes irreversible damage to the liver and shortened life expectancy. The aim of this study was to evaluate the impact of cirrhosis on treatment response and survival in type 1 autoimmune hepatitis. One hundred twenty-eight patients were evaluated for histological cirrhosis. Response to treatment, predictors for cirrhosis, and outcomes were determined. Thirty-seven patients (29%) had histological cirrhosis at entry, whereas 36 of the 91 patients without cirrhosis (40%) developed it during 39 +/- 32 months. Development of cirrhosis was predicted by lower serum albumin levels (P=0.04) and higher prothrombin times (P<0.001) at presentation. The frequencies of remission, relapse after drug withdrawal, and treatment failure were comparable in patients with and without cirrhosis at entry. The overall 10-year survival (93%) was similar to that of an age-and sex-matched cohort from the population at large (94%). Ten-year survival was not different between those with and those without cirrhosis at entry (89% and 90%, respectively), even with transplantation as an end point. Patients with histological cirrhosis at presentation respond to corticosteroid therapy as well as patients without cirrhosis. Low serum albumin levels a...Continue Reading

Citations

Oct 23, 2009·Hepatology International·Yasuhiro MiyakeKazuhide Yamamoto
Jan 6, 2006·The New England Journal of Medicine·Edward L Krawitt
Jan 1, 2009·Therapeutic Advances in Gastroenterology·Gideon M HirschfieldE Jenny Heathcote
May 20, 2009·World Journal of Gastroenterology : WJG·Albert J Czaja, Yusuf Bayraktar
Feb 25, 2010·World Journal of Gastroenterology : WJG·Albert J Czaja
May 7, 2011·World Journal of Gastroenterology : WJG·Jonathan R Potts, Sumita Verma
Oct 6, 2011·Archives of Pathology & Laboratory Medicine·Rachel Hudacko, Neil Theise
Aug 29, 1998·Postgraduate Medicine·E L Krawitt
Jan 20, 2010·Scandinavian Journal of Gastroenterology·Mårten WernerAke Danielsson
Aug 4, 2010·Expert Review of Gastroenterology & Hepatology·Albert J Czaja
Oct 1, 2007·Expert Review of Gastroenterology & Hepatology·Albert J Czaja
Jun 26, 2014·Expert Opinion on Pharmacotherapy·Albert J Czaja
Jan 1, 2006·Expert Review of Clinical Immunology·Albert J Czaja
Jun 1, 2012·Expert Review of Gastroenterology & Hepatology·Rodrigo Liberal, Diego Vergani
Jun 3, 2009·Expert Review of Gastroenterology & Hepatology·Albert J Czaja
May 9, 2008·Expert Opinion on Drug Safety·Albert J Czaja
Jan 26, 2006·Expert Opinion on Pharmacotherapy·Michael A HeneghanIan G McFarlane
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D J ReichP A Sheiner
Feb 4, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Samuel H SigalSwan N Thung
Feb 4, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Albert J CzajaMikio Zeniya
Dec 12, 2012·Journal of Autoimmunity·Rodrigo LiberalDiego Vergani
Jan 19, 2016·Current Gastroenterology Reports·Craig LammertSamer Gawrieh
Mar 15, 2011·Gastroenterology·Barbara HoeroldtDermot Gleeson
Aug 3, 2010·La Revue de médecine interne·C Corpechot, O Chazouillères
Aug 21, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Einar BjörnssonKeith Lindor
May 11, 2010·Gastroenterology·Albert J Czaja, Michael P Manns
Feb 19, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Kadakkal R RadhakrishnanAriel E Feldstein
Sep 19, 2009·Gastroentérologie Clinique Et Biologique·O Chazouillères
Jan 5, 2002·Mayo Clinic Proceedings·J A Al-Khalidi, A J Czaja
Feb 13, 2015·Intractable & Rare Diseases Research·Tomohiro TanakaNorihiro Kokudo
Oct 5, 2002·Clinics in Liver Disease·Herschel A Carpenter, Albert J Czaja
Oct 5, 2002·Clinics in Liver Disease·Albert J Czaja
Oct 9, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Thawab Al-ChalabiMichael A Heneghan
May 24, 2008·Gastroenterology Clinics of North America·Bruce A Luxon
Mar 11, 2008·Lancet·Detlef Schuppan, Nezam H Afdhal
Jun 15, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordan J FeldE Jenny Heathcote
Jul 7, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Srinivas SeelaJames L Boyer
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Albert J Czaja, Herschel A Carpenter
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael P Manns, Arndt Vogel
Dec 2, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Aya Miyagawa-HayashinoToshiaki Manabe
Aug 21, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sumita VermaPaul J Thuluvath
Apr 1, 2008·Journal of Gastroenterology and Hepatology·Suk SeoMyron J Tong
Sep 21, 2006·Alimentary Pharmacology & Therapeutics·A FloreaniM Durazzo
Aug 30, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Andrew D YeomanMichael A Heneghan
Jan 18, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rupert AbdalianE Jenny Heathcote

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The Medical Clinics of North America
Lina MackelaiteKarthik Ranganna
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Raymond U OsarogiagbonThomas O'Brien
Seminars in Oncology Nursing
C L Vogel
The American Journal of Medicine
S L Friedman
© 2021 Meta ULC. All rights reserved